tetano
Editor, Senior Moderator
Clin Immunol
. 2024 Apr 18:110220.
doi: 10.1016/j.clim.2024.110220. Online ahead of print. Cutaneous adverse reactions associated with COVID-19 vaccines: Current evidence and potential immune mechanisms
Po-Chien Wu[SUP] 1 [/SUP], Wan-Chen Lin[SUP] 2 [/SUP], Chuang-Wei Wang[SUP] 3 [/SUP], Wen-Hung Chung[SUP] 4 [/SUP], Chun-Bing Chen[SUP] 5 [/SUP]
Affiliations
As the number of vaccinated individuals has increased, there have been increasing reports of cutaneous hypersensitivity reactions. The main COVID-19 vaccines administered include messenger ribonucleic acid vaccines, non-replicating viral vector vaccines, inactivated whole-virus vaccines, and protein-based vaccines. These vaccines contain active components such as polyethylene glycol, polysorbate 80, aluminum, tromethamine, and disodium edetate dihydrate. Recent advances in understanding the coordination of inflammatory responses by specific subsets of lymphocytes have led to a new classification based on immune response patterns. We categorize these responses into four patterns: T helper (Th)1-, Th2-, Th17/22-, and Treg-polarized cutaneous inflammation after stimulation of COVID-19 vaccines. Although the association between COVID-19 vaccination and these cutaneous adverse reactions remains controversial, the occurrence of rare dermatoses and their short intervals suggest a possible relationship. Despite the potential adverse reactions, the administration of COVID-19 vaccines is crucial in the ongoing battle against severe acute respiratory syndrome coronavirus 2.
Keywords: COVID-19; Cutaneous adverse reactions; Hypersensitivity reactions; Vaccines.
. 2024 Apr 18:110220.
doi: 10.1016/j.clim.2024.110220. Online ahead of print. Cutaneous adverse reactions associated with COVID-19 vaccines: Current evidence and potential immune mechanisms
Po-Chien Wu[SUP] 1 [/SUP], Wan-Chen Lin[SUP] 2 [/SUP], Chuang-Wei Wang[SUP] 3 [/SUP], Wen-Hung Chung[SUP] 4 [/SUP], Chun-Bing Chen[SUP] 5 [/SUP]
Affiliations
- PMID: 38642783
- DOI: 10.1016/j.clim.2024.110220
As the number of vaccinated individuals has increased, there have been increasing reports of cutaneous hypersensitivity reactions. The main COVID-19 vaccines administered include messenger ribonucleic acid vaccines, non-replicating viral vector vaccines, inactivated whole-virus vaccines, and protein-based vaccines. These vaccines contain active components such as polyethylene glycol, polysorbate 80, aluminum, tromethamine, and disodium edetate dihydrate. Recent advances in understanding the coordination of inflammatory responses by specific subsets of lymphocytes have led to a new classification based on immune response patterns. We categorize these responses into four patterns: T helper (Th)1-, Th2-, Th17/22-, and Treg-polarized cutaneous inflammation after stimulation of COVID-19 vaccines. Although the association between COVID-19 vaccination and these cutaneous adverse reactions remains controversial, the occurrence of rare dermatoses and their short intervals suggest a possible relationship. Despite the potential adverse reactions, the administration of COVID-19 vaccines is crucial in the ongoing battle against severe acute respiratory syndrome coronavirus 2.
Keywords: COVID-19; Cutaneous adverse reactions; Hypersensitivity reactions; Vaccines.